Theromics Appoints Andrew C. Zeringue as Chief Executive Officer
Theromics Inc. has appointed Andrew C. Zeringue as Chief Executive Officer, bringing…
Boston Scientific Announces Strategic Investment in MiRus LLC
Boston Scientific announced a $1.5 billion investment in MiRus LLC to support…
GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent
GE HealthCare has dosed the first patient in its Phase 2/3 LUMINA…
Baxter Appoints Andrew Hider Chief Executive Officer
Baxter International Inc, a global medtech leader, announced the appointment of Andrew…
Medtronic Welcomes Dr. Joon Lee to Board, Expands Healthcare Leadership
Medtronic plc, a global leader in healthcare technology, announced that its Board…
